Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle T Amber

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
Journal of the American Academy of Dermatology|July 18, 2015
Private and public coverage policies for rituximab in the treatment of immunobullous disease in the United StatesRomi Bloom, Kyle T Amber
Antioxidants (Basel, Switzerland)|January 20, 2016
A Review of the Use of Topical Calendula in the Prevention and Treatment of Radiotherapy-Induced Skin ReactionsJoyson Kodiyan, Kyle T Amber
International Journal of Palliative Nursing|September 29, 2015
Topical antioxidants in radiodermatitis: a clinical reviewJoyson Kodiyan, Kyle T Amber
JAMA Dermatology|August 17, 2017
Coverage of Intravenous Immunoglobulin for Autoimmune Blistering Diseases Among US InsurersManuel Valdebran, Kyle T Amber
Journal of the European Academy of Dermatology and Venereology : JEADV|July 8, 2023
Two patients with concomitant bullous pemphigoid and psoriasis successfully treated by IL-23 inhibitionConnor Cole, Kyle T Amber
Current Dermatology Reports|October 11, 2022
Off-Label Uses of Rituximab in DermatologyConnor Cole, Kyle T Amber
International Journal of Dermatology|October 22, 2019
Autoimmune blistering diseases provoked during the treatment of chronic inflammatory disease with biologic agents: a systematic reviewFrederick T Gibson, Kyle T Amber
International Journal of Dermatology|October 20, 2017
Second primary cutaneous T-cell lymphoma in patients with non-Hodgkin lymphoma: a chicken-or-the-egg issueJoseph G Kamel, Kyle T Amber
The Journal of Medical Humanities|September 3, 2013
Pharmaceutical ethics and physician liability in Side EffectsGaurav J Dhiman, Kyle T Amber
International Journal of Dermatology|August 18, 2018
Gastrointestinal prophylaxis in patients with autoimmune blistering disease treated with corticosteroids: an expert surveyKyle T Amber, Sergei A Grando
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
Journal of the American Academy of Dermatology|July 18, 2015
Private and public coverage policies for rituximab in the treatment of immunobullous disease in the United StatesRomi Bloom, Kyle T Amber
Antioxidants (Basel, Switzerland)|January 20, 2016
A Review of the Use of Topical Calendula in the Prevention and Treatment of Radiotherapy-Induced Skin ReactionsJoyson Kodiyan, Kyle T Amber
International Journal of Palliative Nursing|September 29, 2015
Topical antioxidants in radiodermatitis: a clinical reviewJoyson Kodiyan, Kyle T Amber
JAMA Dermatology|August 17, 2017
Coverage of Intravenous Immunoglobulin for Autoimmune Blistering Diseases Among US InsurersManuel Valdebran, Kyle T Amber
Journal of the European Academy of Dermatology and Venereology : JEADV|July 8, 2023
Two patients with concomitant bullous pemphigoid and psoriasis successfully treated by IL-23 inhibitionConnor Cole, Kyle T Amber
Current Dermatology Reports|October 11, 2022
Off-Label Uses of Rituximab in DermatologyConnor Cole, Kyle T Amber
International Journal of Dermatology|October 22, 2019
Autoimmune blistering diseases provoked during the treatment of chronic inflammatory disease with biologic agents: a systematic reviewFrederick T Gibson, Kyle T Amber
International Journal of Dermatology|October 20, 2017
Second primary cutaneous T-cell lymphoma in patients with non-Hodgkin lymphoma: a chicken-or-the-egg issueJoseph G Kamel, Kyle T Amber
The Journal of Medical Humanities|September 3, 2013
Pharmaceutical ethics and physician liability in Side EffectsGaurav J Dhiman, Kyle T Amber
International Journal of Dermatology|August 18, 2018
Gastrointestinal prophylaxis in patients with autoimmune blistering disease treated with corticosteroids: an expert surveyKyle T Amber, Sergei A Grando
Pageof 15